We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
-5.17%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
-$821M
(-12%)
Cap. Flow
-$392M
Cap. Flow
% of AUM
-6.36%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
911
New
217
Increased
113
Reduced
100
Closed
202
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$100M |
| 2 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$97M |
| 3 |
Lam Research
LRCX
|
+$85.4M |
| 4 |
Boston Scientific
BSX
|
+$79.4M |
| 5 |
Merck
MRK
|
+$67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$145M |
| 2 |
ASML
ASML
|
+$119M |
| 3 |
Qorvo
QRVO
|
+$89M |
| 4 |
Microsoft
MSFT
|
+$82.9M |
| 5 |
Intuitive Surgical
ISRG
|
+$75.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.56% |
| 2 | Technology | 29.01% |
| 3 | Industrials | 8.79% |
| 4 | Communication Services | 5.99% |
| 5 | Financials | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SJI
101
DELISTED
South Jersey Industries, Inc.
SJI
| $18.9M | 0.31% |
+547,009
| New | +$15.8M |
|
102
Viavi Solutions
VIAV
$9.6B
| $18.8M | 0.3% |
1,166,836
-2,206,176
| -65% | -$36.4M |
|
|
NUVA
103
DELISTED
NuVasive, Inc.
NUVA
| $18.6M | 0.3% |
328,269
+52,162
| +19% | +$2.77M |
|
104
Zscaler
ZS
$26.1B
| $18.5M | 0.3% |
+76,698
| New | +$18.8M |
|
105
Honeywell
HON
$78.6B
| $18.4M | 0.3% |
+100,434
| New | +$18.6M |
|
106
Playtika
PLTK
$1.48B
| $18.4M | 0.3% |
951,517
+269,345
| +39% | +$4.79M |
|
107
Marvell Technology
MRVL
$189B
| $18.1M | 0.29% |
+253,028
| New | +$18.2M |
|
108
Lumentum
LITE
$64.3B
| $17.9M | 0.29% |
+183,093
| New | +$17.9M |
|
109
Ericsson
ERIC
$33B
| $17.7M | 0.29% |
1,939,149
+620,556
| +47% | +$6.46M |
|
110
VeriSign
VRSN
$26.5B
| $17.7M | 0.29% |
+79,388
| New | +$17.3M |
|
111
News Corp Class A
NWSA
$15.7B
| $17.4M | 0.28% |
785,426
-507,708
| -39% | -$11.2M |
|
112
Cirrus Logic
CRUS
$6.53B
| $17.3M | 0.28% |
203,576
-84,815
| -29% | -$7.28M |
|
|
OLK
113
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $17M | 0.28% |
963,796
+168,273
| +21% | +$2.75M |
|
|
RXDX
114
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $17M | 0.28% |
450,258
+199,932
| +80% | +$7.9M |
|
115
SkinHealth Systems
SKIN
$91.4M
| $16.9M | 0.27% |
1,000,992
-547,660
| -35% | -$9.04M |
|
|
LSXMA
116
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $16.9M | 0.27% |
501,969
+484,829
| +2,829% | +$17M |
|
117
Dover
DOV
$28.3B
| $16.8M | 0.27% |
106,872
-3,453
| -3% | -$566K |
|
118
argenx
ARGX
$54.3B
| $16.7M | 0.27% |
+52,979
| New | +$15.4M |
|
119
Procore
PCOR
$8.46B
| $16.7M | 0.27% |
+287,301
| New | +$18.3M |
|
|
IMGO
120
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $16M | 0.26% |
831,830
-16,299
| -2% | -$338K |
|
121
Fortinet
FTNT
$120B
| $15.9M | 0.26% |
+232,210
| New | +$14.4M |
|
122
Supernus Pharmaceuticals
SUPN
$2.73B
| $15.7M | 0.25% |
+485,412
| New | +$14.9M |
|
|
NLSN
123
DELISTED
Nielsen Holdings plc
NLSN
| $15.2M | 0.25% |
+558,000
| New | +$11.1M |
|
124
TransDigm Group
TDG
$70.2B
| $15.1M | 0.24% |
23,140
+15,360
| +197% | +$9.87M |
|
125
PMV Pharmaceuticals
PMVP
$62.4M
| $15M | 0.24% |
718,093
+419,483
| +140% | +$7.4M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q1 2022 Portfolio in Review
As of Q1 2022, Woodline Partners held 911 positions worth $6.16B, down 12% from $6.98B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Woodline Partners withdrew a net $392M in Q1 2022, closing 202 positions and reducing 100 holdings. Its most notable exit was AbbVie, an estimated $145M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.
Against the trend, Woodline Partners opened a new position in ZYNGA INC. CL A COMMON worth $102M.
- Woodline Partners's largest Q1 2022 buy was ZYNGA INC. CL A COMMON: 11,039,458 shares worth $102M.
- Woodline Partners added most to Seagen Inc. Common Stock in Q1 2022, an estimated $100M increase.
- Woodline Partners's biggest Q1 2022 reduction was Qorvo, cutting an estimated $89M.
- Woodline Partners fully exited AbbVie in Q1 2022, selling an estimated $145M.
- Woodline Partners's ten largest holdings make up 16% of its $6.16B portfolio in Q1 2022.
- Woodline Partners opened 217 new positions and closed 202 in Q1 2022.
- Woodline Partners's portfolio value fell 12% quarter-over-quarter to $6.16B.
Based on Woodline Partners's 13F filing for Q1 2022, filed 16 May 2022.